AstraZeneca-Amgen asthma drug gets US approval
20th Dec 2021 07:42
(Sharecast News) - The AstraZeneca-Amgen asthma drug Tezspire has been approved by the US Food and Drug Administration to treat of adult and paediatric patients aged 12 years and older, the two companies said on Monday.
Read moreAstraZeneca lupus treatment wins EU marketing approval
20th Dec 2021 07:21
(Sharecast News) - AstraZeneca's lupus treatment has received marketing authorisation by the European Union, the company said on Monday.
Read moreOmicron results in fewer hospitalisations and ICU admissions, SA study shows
14th Dec 2021 09:57
(Sharecast News) - The newest variant of the SARS-CoV-2 coronavirus has resulted in fewer hospitalisations and intensive care unit admissions than previous waves of Covid-19, the results of a new study show.
Read moreBerenberg slightly lowers target price on AstraZeneca
10th Dec 2021 10:46
(Sharecast News) - Analysts at Berenberg slightly lowered their target price on drugmaker AstraZeneca from 105.0p to 100.0p on Friday but said they were "optimistic" about the firm's pipeline destiny.
Read moreFDA grants emergency use for AstraZeneca's Covid-19 preventative
9th Dec 2021 07:55
(Sharecast News) - AstraZeneca said on Thursday that its Evusheld antibody combination has been granted emergency use authorisation by the US Food and Drug Administration for the prevention of Covid-19 in adults and adolescents who are immunocompromised.
Read moreAstraZeneca strikes development and commercialisation deal with Ionis
7th Dec 2021 07:45
(Sharecast News) - Drugmaker AstraZeneca has struck a deal with Ionis Pharmaceuticals that will see the pair work together to develop and commercialise its investigational medicine Eplontersen.
Read moreTwo Hutchmed drugs included in China's 2022 reimbursement list
3rd Dec 2021 13:23
(Sharecast News) - Hutchmed China announced on Friday that, following negotiations with the China National Healthcare Security Administration (NHSA), from 1 January the updated National Reimbursement Drug List (NRDL) will continue to include 'Elunate', or fruquintinib, and would now include 'Sulanda', or surufatinib.
Read moreOmicron cases outside South Africa no deadlier, Australian official says
2nd Dec 2021 08:40
(Sharecast News) - On current evidence, the Omicron variant of Covid-19 did not yet appear to be any deadlier than previous ones, Australian health officials said.
Read moreAll confirmed Omicron cases in EU thus far are asymptomatic or have shown mild symptoms
30th Nov 2021 21:49
(Sharecast News) - All confirmed cases of the Omicron variant of concern detected thus far in the European Union had thus far had been either asymptomatic or shown "mild" symptoms, the bloc's pandemic watchdog said.
Read moreAstraZeneca Lynparza supplemental application gets US priority review
30th Nov 2021 07:31
(Sharecast News) - AstraZeneca said that its Lynparza breast cancer drug's supplemental new application had been accepted and granted Priority Review by the US Food and Drug Administration.
Read moreOmicron likely to fall 'some way short' of apocalyptic reboot of pandemic, Pantheon Macro says
28th Nov 2021 22:24
(Sharecast News) - Analysts at Pantheon Macroeconomics believed the most likely outcome from the appearance of the new SARS-CoV-2 variant, Omicron, would be "some way short of an apocalyptic reboot of the pandemic."
Read moreNew Covid variant triggers alarm bells around the world
26th Nov 2021 16:09
(Sharecast News) - Authorities in the UK and many other European countries moved quickly to cut travel links with South Africa and several other countries in southern Africa following the detection of a new variant of Covid-19 with a large number of mutations on the so-called 'spike' protein.
Read moreNew UK Covid variant may be less likely to cause symptoms, study shows
18th Nov 2021 14:52
(Sharecast News) - The fast-spreading variant of Covid-19 recently detected in the UK may be less likely to cause symptoms, the results of new research showed.
Read moreAstraZeneca antibody found to reduce risk of severe Covid-19 by over 80pc
18th Nov 2021 07:40
(Sharecast News) - AstraZeneca reported positive findings from recent studies into its Covid-19 antibody treatment on Thursday, reporting that when given to at-risk and immunocompromised patients before exposure to the coronavirus, it reduced the risk of developing severe disease by 83%.
Read moreAstraZeneca holds guidance as Covid vaccine turns profitable
12th Nov 2021 07:03
(Sharecast News) - AstraZeneca on Friday reported $1.05bn in third-quarter Covid vaccine sales as the not-for-profit drug added 1% to earnings in the period, while the company reiterated annual forecasts for 2021.
Read more